世界の髄膜炎菌感染症ワクチン市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Meningococcal Infections Vaccine Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4491 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、85ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、髄膜炎菌感染症ワクチンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（4価（血清型A＆C＆W-135＆Y）、2価（血清型C＆Y）、血清型A、血清型B、血清型X）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・髄膜炎菌感染症ワクチンの市場動向 ・企業の競争状況、市場シェア ・髄膜炎菌感染症ワクチンの種類別市場規模と予測2016-2027（4価（血清型A＆C＆W-135＆Y）、2価（血清型C＆Y）、血清型A、血清型B、血清型X） ・髄膜炎菌感染症ワクチンの用途別市場規模と予測2016-2027（病院、クリニック） ・髄膜炎菌感染症ワクチンの北米市場規模2016-2027（アメリカ、カナダ） ・髄膜炎菌感染症ワクチンの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・髄膜炎菌感染症ワクチンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・髄膜炎菌感染症ワクチンの中南米市場規模2016-2027（メキシコ、ブラジル） ・髄膜炎菌感染症ワクチンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Creative Biolabs(USA)、SERUM INSTITUTE OF INDIA PVT.LTD.(India)） ・結論

Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitidis.Different versions are effective against some or all of the following types of meningococcus: A, C, W-135,and Y.The vaccines are between 85 and 100% effective for at least two years.They result in a decrease in meningitis and sepsis among populations where they are widely used.They are given either by injection into a muscle or just under the skin.

Market Analysis and Insights: Global Meningococcal Infections Vaccine Market
The global Meningococcal Infections Vaccine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Meningococcal Infections Vaccine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Meningococcal Infections Vaccine market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Meningococcal Infections Vaccine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Meningococcal Infections Vaccine market.

Global Meningococcal Infections Vaccine Scope and Market Size
Meningococcal Infections Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Meningococcal Infections Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Quadrivalent (Serogroups A, C, W-135, and Y)
Bivalent (Serogroups C and Y)
Serogroup A
Serogroup B
Serogroup X

Segment by Application
Hospital
Clinic

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Creative Biolabs(USA)
SERUM INSTITUTE OF INDIA PVT.LTD.(India)

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Meningococcal Infections Vaccine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Quadrivalent (Serogroups A, C, W-135, and Y)
1.2.3 Bivalent (Serogroups C and Y)
1.2.4 Serogroup A
1.2.5 Serogroup B
1.2.6 Serogroup X
1.3 Market by Application
1.3.1 Global Meningococcal Infections Vaccine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Meningococcal Infections Vaccine Market Perspective (2016-2027)
2.2 Meningococcal Infections Vaccine Growth Trends by Regions
2.2.1 Meningococcal Infections Vaccine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Meningococcal Infections Vaccine Historic Market Share by Regions (2016-2021)
2.2.3 Meningococcal Infections Vaccine Forecasted Market Size by Regions (2022-2027)
2.3 Meningococcal Infections Vaccine Industry Dynamic
2.3.1 Meningococcal Infections Vaccine Market Trends
2.3.2 Meningococcal Infections Vaccine Market Drivers
2.3.3 Meningococcal Infections Vaccine Market Challenges
2.3.4 Meningococcal Infections Vaccine Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Meningococcal Infections Vaccine Players by Revenue
3.1.1 Global Top Meningococcal Infections Vaccine Players by Revenue (2016-2021)
3.1.2 Global Meningococcal Infections Vaccine Revenue Market Share by Players (2016-2021)
3.2 Global Meningococcal Infections Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Meningococcal Infections Vaccine Revenue
3.4 Global Meningococcal Infections Vaccine Market Concentration Ratio
3.4.1 Global Meningococcal Infections Vaccine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Meningococcal Infections Vaccine Revenue in 2020
3.5 Meningococcal Infections Vaccine Key Players Head office and Area Served
3.6 Key Players Meningococcal Infections Vaccine Product Solution and Service
3.7 Date of Enter into Meningococcal Infections Vaccine Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Meningococcal Infections Vaccine Breakdown Data by Type
4.1 Global Meningococcal Infections Vaccine Historic Market Size by Type (2016-2021)
4.2 Global Meningococcal Infections Vaccine Forecasted Market Size by Type (2022-2027)

5 Meningococcal Infections Vaccine Breakdown Data by Application
5.1 Global Meningococcal Infections Vaccine Historic Market Size by Application (2016-2021)
5.2 Global Meningococcal Infections Vaccine Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Meningococcal Infections Vaccine Market Size (2016-2027)
6.2 North America Meningococcal Infections Vaccine Market Size by Type
6.2.1 North America Meningococcal Infections Vaccine Market Size by Type (2016-2021)
6.2.2 North America Meningococcal Infections Vaccine Market Size by Type (2022-2027)
6.2.3 North America Meningococcal Infections Vaccine Market Size by Type (2016-2027)
6.3 North America Meningococcal Infections Vaccine Market Size by Application
6.3.1 North America Meningococcal Infections Vaccine Market Size by Application (2016-2021)
6.3.2 North America Meningococcal Infections Vaccine Market Size by Application (2022-2027)
6.3.3 North America Meningococcal Infections Vaccine Market Size by Application (2016-2027)
6.4 North America Meningococcal Infections Vaccine Market Size by Country
6.4.1 North America Meningococcal Infections Vaccine Market Size by Country (2016-2021)
6.4.2 North America Meningococcal Infections Vaccine Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Meningococcal Infections Vaccine Market Size (2016-2027)
7.2 Europe Meningococcal Infections Vaccine Market Size by Type
7.2.1 Europe Meningococcal Infections Vaccine Market Size by Type (2016-2021)
7.2.2 Europe Meningococcal Infections Vaccine Market Size by Type (2022-2027)
7.2.3 Europe Meningococcal Infections Vaccine Market Size by Type (2016-2027)
7.3 Europe Meningococcal Infections Vaccine Market Size by Application
7.3.1 Europe Meningococcal Infections Vaccine Market Size by Application (2016-2021)
7.3.2 Europe Meningococcal Infections Vaccine Market Size by Application (2022-2027)
7.3.3 Europe Meningococcal Infections Vaccine Market Size by Application (2016-2027)
7.4 Europe Meningococcal Infections Vaccine Market Size by Country
7.4.1 Europe Meningococcal Infections Vaccine Market Size by Country (2016-2021)
7.4.2 Europe Meningococcal Infections Vaccine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Meningococcal Infections Vaccine Market Size (2016-2027)
8.2 Asia-Pacific Meningococcal Infections Vaccine Market Size by Type
8.2.1 Asia-Pacific Meningococcal Infections Vaccine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Meningococcal Infections Vaccine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Meningococcal Infections Vaccine Market Size by Type (2016-2027)
8.3 Asia-Pacific Meningococcal Infections Vaccine Market Size by Application
8.3.1 Asia-Pacific Meningococcal Infections Vaccine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Meningococcal Infections Vaccine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Meningococcal Infections Vaccine Market Size by Application (2016-2027)
8.4 Asia-Pacific Meningococcal Infections Vaccine Market Size by Region
8.4.1 Asia-Pacific Meningococcal Infections Vaccine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Meningococcal Infections Vaccine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Meningococcal Infections Vaccine Market Size (2016-2027)
9.2 Latin America Meningococcal Infections Vaccine Market Size by Type
9.2.1 Latin America Meningococcal Infections Vaccine Market Size by Type (2016-2021)
9.2.2 Latin America Meningococcal Infections Vaccine Market Size by Type (2022-2027)
9.2.3 Latin America Meningococcal Infections Vaccine Market Size by Type (2016-2027)
9.3 Latin America Meningococcal Infections Vaccine Market Size by Application
9.3.1 Latin America Meningococcal Infections Vaccine Market Size by Application (2016-2021)
9.3.2 Latin America Meningococcal Infections Vaccine Market Size by Application (2022-2027)
9.3.3 Latin America Meningococcal Infections Vaccine Market Size by Application (2016-2027)
9.4 Latin America Meningococcal Infections Vaccine Market Size by Country
9.4.1 Latin America Meningococcal Infections Vaccine Market Size by Country (2016-2021)
9.4.2 Latin America Meningococcal Infections Vaccine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Meningococcal Infections Vaccine Market Size (2016-2027)
10.2 Middle East & Africa Meningococcal Infections Vaccine Market Size by Type
10.2.1 Middle East & Africa Meningococcal Infections Vaccine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Meningococcal Infections Vaccine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Meningococcal Infections Vaccine Market Size by Type (2016-2027)
10.3 Middle East & Africa Meningococcal Infections Vaccine Market Size by Application
10.3.1 Middle East & Africa Meningococcal Infections Vaccine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Meningococcal Infections Vaccine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Meningococcal Infections Vaccine Market Size by Application (2016-2027)
10.4 Middle East & Africa Meningococcal Infections Vaccine Market Size by Country
10.4.1 Middle East & Africa Meningococcal Infections Vaccine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Meningococcal Infections Vaccine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Creative Biolabs(USA)
11.1.1 Creative Biolabs(USA) Company Details
11.1.2 Creative Biolabs(USA) Business Overview
11.1.3 Creative Biolabs(USA) Meningococcal Infections Vaccine Introduction
11.1.4 Creative Biolabs(USA) Revenue in Meningococcal Infections Vaccine Business (2016-2021)
11.1.5 Creative Biolabs(USA) Recent Development
11.2 SERUM INSTITUTE OF INDIA PVT.LTD.(India)
11.2.1 SERUM INSTITUTE OF INDIA PVT.LTD.(India) Company Details
11.2.2 SERUM INSTITUTE OF INDIA PVT.LTD.(India) Business Overview
11.2.3 SERUM INSTITUTE OF INDIA PVT.LTD.(India) Meningococcal Infections Vaccine Introduction
11.2.4 SERUM INSTITUTE OF INDIA PVT.LTD.(India) Revenue in Meningococcal Infections Vaccine Business (2016-2021)
11.2.5 SERUM INSTITUTE OF INDIA PVT.LTD.(India) Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Meningococcal Infections Vaccine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Quadrivalent (Serogroups A, C, W-135, and Y)
Table 3. Key Players of Bivalent (Serogroups C and Y)
Table 4. Key Players of Serogroup A
Table 5. Key Players of Serogroup B
Table 6. Key Players of Serogroup X
Table 7. Global Meningococcal Infections Vaccine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Meningococcal Infections Vaccine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Meningococcal Infections Vaccine Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Meningococcal Infections Vaccine Market Share by Regions (2016-2021)
Table 11. Global Meningococcal Infections Vaccine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Meningococcal Infections Vaccine Market Share by Regions (2022-2027)
Table 13. Meningococcal Infections Vaccine Market Trends
Table 14. Meningococcal Infections Vaccine Market Drivers
Table 15. Meningococcal Infections Vaccine Market Challenges
Table 16. Meningococcal Infections Vaccine Market Restraints
Table 17. Global Meningococcal Infections Vaccine Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Meningococcal Infections Vaccine Market Share by Players (2016-2021)
Table 19. Global Top Meningococcal Infections Vaccine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningococcal Infections Vaccine as of 2020)
Table 20. Ranking of Global Top Meningococcal Infections Vaccine Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Meningococcal Infections Vaccine Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Meningococcal Infections Vaccine Product Solution and Service
Table 24. Date of Enter into Meningococcal Infections Vaccine Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Meningococcal Infections Vaccine Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Meningococcal Infections Vaccine Revenue Market Share by Type (2016-2021)
Table 28. Global Meningococcal Infections Vaccine Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Meningococcal Infections Vaccine Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Meningococcal Infections Vaccine Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Meningococcal Infections Vaccine Revenue Market Share by Application (2016-2021)
Table 32. Global Meningococcal Infections Vaccine Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Meningococcal Infections Vaccine Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Meningococcal Infections Vaccine Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Meningococcal Infections Vaccine Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Meningococcal Infections Vaccine Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Meningococcal Infections Vaccine Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Meningococcal Infections Vaccine Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Meningococcal Infections Vaccine Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Meningococcal Infections Vaccine Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Meningococcal Infections Vaccine Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Meningococcal Infections Vaccine Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Meningococcal Infections Vaccine Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Meningococcal Infections Vaccine Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Meningococcal Infections Vaccine Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Meningococcal Infections Vaccine Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Meningococcal Infections Vaccine Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Meningococcal Infections Vaccine Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Meningococcal Infections Vaccine Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Meningococcal Infections Vaccine Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Meningococcal Infections Vaccine Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Meningococcal Infections Vaccine Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Meningococcal Infections Vaccine Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Meningococcal Infections Vaccine Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Meningococcal Infections Vaccine Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Meningococcal Infections Vaccine Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Meningococcal Infections Vaccine Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Meningococcal Infections Vaccine Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Meningococcal Infections Vaccine Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Meningococcal Infections Vaccine Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Meningococcal Infections Vaccine Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Meningococcal Infections Vaccine Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Meningococcal Infections Vaccine Market Size by Country (2022-2027) & (US$ Million)
Table 64. Creative Biolabs(USA) Company Details
Table 65. Creative Biolabs(USA) Business Overview
Table 66. Creative Biolabs(USA) Meningococcal Infections Vaccine Product
Table 67. Creative Biolabs(USA) Revenue in Meningococcal Infections Vaccine Business (2016-2021) & (US$ Million)
Table 68. Creative Biolabs(USA) Recent Development
Table 69. SERUM INSTITUTE OF INDIA PVT.LTD.(India) Company Details
Table 70. SERUM INSTITUTE OF INDIA PVT.LTD.(India) Business Overview
Table 71. SERUM INSTITUTE OF INDIA PVT.LTD.(India) Meningococcal Infections Vaccine Product
Table 72. SERUM INSTITUTE OF INDIA PVT.LTD.(India) Revenue in Meningococcal Infections Vaccine Business (2016-2021) & (US$ Million)
Table 73. SERUM INSTITUTE OF INDIA PVT.LTD.(India) Recent Development
Table 74. Research Programs/Design for This Report
Table 75. Key Data Information from Secondary Sources
Table 76. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Meningococcal Infections Vaccine Market Share by Type: 2020 VS 2027
Figure 2. Quadrivalent (Serogroups A, C, W-135, and Y) Features
Figure 3. Bivalent (Serogroups C and Y) Features
Figure 4. Serogroup A Features
Figure 5. Serogroup B Features
Figure 6. Serogroup X Features
Figure 7. Global Meningococcal Infections Vaccine Market Share by Application: 2020 VS 2027
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Meningococcal Infections Vaccine Report Years Considered
Figure 11. Global Meningococcal Infections Vaccine Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Meningococcal Infections Vaccine Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Meningococcal Infections Vaccine Market Share by Regions: 2020 VS 2027
Figure 14. Global Meningococcal Infections Vaccine Market Share by Regions (2022-2027)
Figure 15. Global Meningococcal Infections Vaccine Market Share by Players in 2020
Figure 16. Global Top Meningococcal Infections Vaccine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningococcal Infections Vaccine as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Meningococcal Infections Vaccine Revenue in 2020
Figure 18. Global Meningococcal Infections Vaccine Revenue Market Share by Type (2016-2021)
Figure 19. Global Meningococcal Infections Vaccine Revenue Market Share by Type (2022-2027)
Figure 20. North America Meningococcal Infections Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Meningococcal Infections Vaccine Market Share by Type (2016-2027)
Figure 22. North America Meningococcal Infections Vaccine Market Share by Application (2016-2027)
Figure 23. North America Meningococcal Infections Vaccine Market Share by Country (2016-2027)
Figure 24. United States Meningococcal Infections Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Meningococcal Infections Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Meningococcal Infections Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Meningococcal Infections Vaccine Market Share by Type (2016-2027)
Figure 28. Europe Meningococcal Infections Vaccine Market Share by Application (2016-2027)
Figure 29. Europe Meningococcal Infections Vaccine Market Share by Country (2016-2027)
Figure 30. Germany Meningococcal Infections Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Meningococcal Infections Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Meningococcal Infections Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Meningococcal Infections Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Meningococcal Infections Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Meningococcal Infections Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Meningococcal Infections Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Meningococcal Infections Vaccine Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Meningococcal Infections Vaccine Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Meningococcal Infections Vaccine Market Share by Region (2016-2027)
Figure 40. China Meningococcal Infections Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Meningococcal Infections Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Meningococcal Infections Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Meningococcal Infections Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Meningococcal Infections Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Meningococcal Infections Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Meningococcal Infections Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Meningococcal Infections Vaccine Market Share by Type (2016-2027)
Figure 48. Latin America Meningococcal Infections Vaccine Market Share by Application (2016-2027)
Figure 49. Latin America Meningococcal Infections Vaccine Market Share by Country (2016-2027)
Figure 50. Mexico Meningococcal Infections Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Meningococcal Infections Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Meningococcal Infections Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Meningococcal Infections Vaccine Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Meningococcal Infections Vaccine Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Meningococcal Infections Vaccine Market Share by Country (2016-2027)
Figure 56. Turkey Meningococcal Infections Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Meningococcal Infections Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Meningococcal Infections Vaccine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Creative Biolabs(USA) Revenue Growth Rate in Meningococcal Infections Vaccine Business (2016-2021)
Figure 60. SERUM INSTITUTE OF INDIA PVT.LTD.(India) Revenue Growth Rate in Meningococcal Infections Vaccine Business (2016-2021)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

---